Today, thanks to early diagnosis, personalized therapies, and rapidly evolving research, cancer can increasingly be managed with the right approach.
Every person diagnosed with cancer deserves access to the most accurate and up-to-date treatment supported by scientific evidence.
Prof. Dr. Ibrahim Yildiz
Medical Oncology and Internal Medicine Specialist
Medical Oncology and Internal Medicine Specialist
Evidence-based, personalized, and multidisciplinary treatment pathways
Recent developments, scientific updates, and patient information that complement treatment decisions.
Thirteen real cases where a molecular second opinion changed the treatment decision. The same report can lead to an ineffective therapy when misread, or a transformative opportunity when read correctly.
Read ArticleI began my medical education at Istanbul University Cerrahpasa Faculty of Medicine and graduated in 2002. After graduation, I completed my Internal Medicine residency between 2003 and 2008 and my Medical Oncology subspecialty training between 2010 and 2013.
Since 2015, I have been serving within the Acibadem Healthcare Group. I continue my academic work as a professor at Acibadem Mehmet Ali Aydinlar University.
I actively continue my scientific work with more than 100 peer-reviewed international publications, numerous presentations, and book chapters.
I also provide care for international patients from the Balkans, Africa, and Central Asia, with a strong focus on rare tumors and molecularly targeted treatments.
Prof. Dr. Ibrahim Yildiz
Medical Oncology and Internal Medicine Specialist | Acibadem Mehmet Ali Aydinlar University
Scientific, personalized, and internationally aligned oncology care
Expert oncologist review of next-generation sequencing reports with personalized treatment recommendations
A network of multidisciplinary and molecular tumor boards meeting 9 times a week across different tumor groups
Coordinated healthcare support for patients coming from the Balkans, Central Asia, Africa, and the Middle East
Moments we share with our patients throughout the treatment journey
A detailed specialist review of your next-generation sequencing report by an expert oncologist
You can share your solid tumor or liquid biopsy NGS panel reports from platforms such as Tempus, FoundationOne, Caris MI, Guardant, and similar services.
Our structured 12-section molecular consultation report evaluates all mutations, treatment options, and relevant clinical research opportunities.
A detailed report is delivered including treatment recommendations, suitable clinical trials, and molecular tumor board insight.
You can contact us with your questions or submit an appointment request
Acibadem Atakent Hospital
Halkali Merkez Mah. Turgut Ozal Bulvari No:16
Kucukcekmece, Istanbul
Monday - Friday: 09:00 - 18:00